| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/19/2000 | EP0994107A1 5-Arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 04/19/2000 | EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them |
| 04/19/2000 | EP0993458A1 3-benzylpiperidine |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993450A1 New compounds |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993305A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 04/19/2000 | EP0686144B1 New compounds |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251112A Cross-linked vinyl polymers with bile acid adsorbing effect |
| 04/19/2000 | CN1251100A Method for making arylamino triazolopyridines |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250662A Medicine 'Maikang' for treating vasculitis |
| 04/19/2000 | CN1250651A Medicinal composition for preventing and curing intracranial hypertension |
| 04/19/2000 | CN1250618A Food additive benefiting patients of diabetics, coronary heart disease and tumor and its preparing method |
| 04/19/2000 | CN1051546C Novel 1,1-bis(heteroazolyl) alkane derivatives and their use as neuroprotective agents |
| 04/19/2000 | CN1051545C 5-(aryloxymethyl) oxazolines, process for prepn. thereof and pharmaceutical compositions contg. same |
| 04/18/2000 | US6051712 Piperidine derivatives having renin inhibiting activity |
| 04/18/2000 | US6051599 Endothelin receptor antagonists |
| 04/18/2000 | US6051587 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| 04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
| 04/18/2000 | US6051571 Methods for treating medical dysfunctions and diseases using furan nitrone compounds |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/18/2000 | US6051241 Administering to a patient in need thereof an effective amount of a gaseous medication comprising nitrogen monoxide and carbon dioxide by intra-abdominal route for treatment or prevention of hypoperfusions of abdominal organs |
| 04/18/2000 | CA2166700C Heterocyclic amines having central nervous system activity |
| 04/18/2000 | CA1340964C Crf analogs |
| 04/18/2000 | CA1340960C Chroman derivatives |
| 04/13/2000 | WO2000020634A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020572A2 Tissue binding peptides, identification, production and utilization thereof |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020443A1 Novel peptides |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | WO2000020420A1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
| 04/13/2000 | WO2000020416A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 04/13/2000 | WO2000020410A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020394A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 04/13/2000 | WO2000020392A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020025A2 Akt compositions for enhancing survival of cells |
| 04/13/2000 | WO2000020019A2 A composition for the prevention and/or treatment of atherosclerosis |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO2000019883A2 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | WO2000019824A1 Novel treatment for stroke management |
| 04/13/2000 | WO2000002877A3 New pharmaceutically active compounds |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/13/2000 | DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | DE19845403A1 Mit Gallensäuren verknüpfte Porpanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Porpanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | DE19845402A1 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/13/2000 | DE19842416A1 Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden Secondary amines for the prevention and treatment of diseases that are caused or aggravated by oxidation processes |
| 04/13/2000 | CA2354544A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346765A1 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | CA2346665A1 Novel treatment for stroke management |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346085A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | CA2346083A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2346033A1 Imidazo[4,5-c-]-pyridin-4-one(sic) derivatives having factor xa-inhibiting action |
| 04/13/2000 | CA2346019A1 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | CA2345997A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345789A1 New crystal modification iii of torasemide |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345214A1 Tissue binding peptides, identification, production and utilization thereof |
| 04/13/2000 | CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344765A1 Novel peptides |
| 04/13/2000 | CA2344551A1 P-conotoxin peptide |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992510A1 N6 heterocyclic substituted adenosine derivatives |
| 04/12/2000 | EP0992496A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors |
| 04/12/2000 | EP0992495A1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 04/12/2000 | EP0992243A1 Prophylactic/remedial agent |
| 04/12/2000 | EP0991758A1 Smad6 and uses thereof |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991647A1 Eprosartan monohydrate |
| 04/12/2000 | EP0991639A1 4- (1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |